These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36049186)

  • 1. Comprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care Patients.
    Mihailescu-Marin MM; Mosoiu DV; Dima L
    Am J Ther; 2022 Sep-Oct 01; 29(5):e512-e519. PubMed ID: 36049186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.
    Bechakra M; Moerdijk F; van Rosmalen J; Koch BCP; van der Rijt CCD; Sillevis Smitt PAE; Jongen JLM
    Eur J Cancer; 2018 Dec; 105():79-87. PubMed ID: 30439627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone and neuropathic cancer pain subcomponents: a prospective cohort pilot study.
    Fawoubo A; Perceau-Chambard É; Ruer M; Filbet M; Tricou C; Economos G
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e273-e277. PubMed ID: 34620692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
    Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
    Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
    Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
    BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and treatment of neuropathic cancer pain following WHO guidelines.
    Grond S; Radbruch L; Meuser T; Sabatowski R; Loick G; Lehmann KA
    Pain; 1999 Jan; 79(1):15-20. PubMed ID: 9928771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association between Patient Characteristics and Opioid Treatment Response in Neuropathic and Nociceptive Pain due to Cancer.
    Haumann J; van Kuijk SMJ; Joosten EA; van den Beuken-van Everdingen MHJ
    J Palliat Med; 2019 Feb; 22(2):157-163. PubMed ID: 30359202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between nociceptive and neuropathic components in chronic low back pain using behavioural evaluation and sensory examination.
    Spahr N; Hodkinson D; Jolly K; Williams S; Howard M; Thacker M
    Musculoskelet Sci Pract; 2017 Feb; 27():40-48. PubMed ID: 28637600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Management of Cancer-Related Pain in Pregnant Patients.
    Zerfas I; McGinn R; Smith MA
    Drugs; 2023 Aug; 83(12):1067-1076. PubMed ID: 37347386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies.
    Moulin DE; Richarz U; Wallace M; Jacobs A; Thipphawong J
    J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):200-12. PubMed ID: 20718640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial.
    Fallon MT; Wilcock A; Kelly CA; Paul J; Lewsley LA; Norrie J; Laird BJA
    JAMA Oncol; 2018 Jun; 4(6):870-872. PubMed ID: 29621378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Malignant Neuropathic Pain in Chinese Patients with Cancer: Report of a Hospital-based Investigation of Prevalence, Etiology, Assessment, and Treatment.
    Lu F; Song L; Xie T; Tian J; Fan Y; Liu H
    Pain Pract; 2017 Jan; 17(1):88-98. PubMed ID: 26991802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor-associated pain].
    Wirz S; Keßler J; Hofbauer H
    Schmerz; 2024 Feb; 38(1):57-69. PubMed ID: 38206419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain.
    Martínez-Navarro M; Lara-Mayorga IM; Negrete R; Bilecki W; Wawrzczak-Bargieła A; Gonçalves L; Dickenson AH; Przewłocki R; Baños JE; Maldonado R
    Neuropharmacology; 2019 Apr; 148():291-304. PubMed ID: 30668942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neuropathic pain in radiotherapy oncology units.
    Mañas A; Monroy JL; Ramos AA; Cano C; López-Gómez V; Masramón X; Pérez M;
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):511-20. PubMed ID: 20832183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of quality of life and neuropathic pain in patients with low back pain using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire.
    Hiyama A; Watanabe M; Katoh H; Sato M; Sakai D; Mochida J
    Eur Spine J; 2015 Mar; 24(3):503-12. PubMed ID: 25502001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic Knowledge of Drug Pain Therapy in the Palliative Situation].
    Weber S; Lampert A; Stingl J; Peuckmann-Post V; Hiddemann S; Elsner F; Neuner I; Rolke R
    Dtsch Med Wochenschr; 2020 Jul; 145(13):917-925. PubMed ID: 32615607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic pain and cannabinoids. Great expectations or a christmas carol.
    Pascual D; Sánchez-Robles EM; García MM; Goicoechea C
    Biochem Pharmacol; 2018 Nov; 157():33-42. PubMed ID: 30056139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
    Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
    Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
    Gül ŞK; Tepetam H; Gül HL
    Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.